Prescient Therapeutics (Prescient Therapeutics) Marketable Securities : $8.05 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Prescient Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Prescient Therapeutics's Marketable Securities for the quarter that ended in Dec. 2023 was $8.05 Mil.

Prescient Therapeutics's annual Marketable Securities declined from Jun. 2021 ($0.02 Mil) to Jun. 2022 ($0.01 Mil) but then increased from Jun. 2022 ($0.01 Mil) to Jun. 2023 ($10.75 Mil).

Prescient Therapeutics Marketable Securities Historical Data

The historical data trend for Prescient Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prescient Therapeutics Marketable Securities Chart

Prescient Therapeutics Annual Data

Trend

Jun13

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Marketable Securities

Get a 7-Day Free Trial

0.01

0.02

0.01

10.75

Prescient Therapeutics Semi-Annual Data
	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	0.01	-	10.75	8.05

Prescient Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Prescient Therapeutics (GREY:PSTTF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Prescient Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Prescient Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Prescient Therapeutics (Prescient Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (GREY:PSTTF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PTX:Australia

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.ptxtherapeutics.com

Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.